Log In
Print this Print this

Anti-Mucin1 (MUC1) CAR T Cells

  Manage Alerts
Collapse Summary General Information
Company PersonGen Biomedicine (Suzhou) Co. Ltd.
DescriptionAnti-Mucin1 (MUC1) CAR T cells
Molecular Target Mucin 1 (MUC1) (CD227)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationSolid tumors
Indication DetailsTreat MUC1 positive advanced refractory solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today